Personal care
Sensodyne ProNamel Toothpaste
Chemistry breakdown
Bar length = weight in the Personal care formula · color = that component's score · tap a name to learn what it means.
Scored from 35% of the formula's weight. The rest doesn't apply to this product.
Endocrine disruptors7.4/10 · 35% weight
Chemicals that can interfere with the body's hormone system — the signals that regulate growth, metabolism and reproduction. Exposure matters most during pregnancy and early childhood, which is why this component carries extra weight in baby products. Common examples under study: certain parabens, phthalates and bisphenols.
Carcinogensnone listed · 25% weight
Ingredients that authoritative bodies (IARC, US NTP) have classified as known or suspected causes of cancer, weighted by the strength of that evidence — 'possibly carcinogenic' is treated very differently from 'known'.
PFASno PFAS listed · 15% weight
Per- and polyfluoroalkyl substances — 'forever chemicals' that persist in the body and environment for years. Used for water- and stain-resistance; linked in studies to immune and developmental effects.
Certificationsnone claimed · 15% weight
Independent third-party verifications (USDA Organic, FSC, EPA Safer Choice…). Informational only — having none never lowers a score; verified claims can raise it.
Fragrance opacityno fragrance listed · 10% weight
US law lets 'fragrance' stand in for dozens of undisclosed chemicals as a trade secret. This measures how much of the scent formula is hidden — not that fragrance is inherently harmful, but that you can't evaluate what isn't disclosed.
Ingredients · 3
In INCI order — the highest-concentration ingredients are listed first. Tap any row for its sources.
Made by
- 2018–2021Talc: Ingham verdict affirmed; internal asbestos knowledge documented — See Kenvue — the conduct predates the 2023 spinoff and originated with Johnson & Johnson. Punitive damages affirmed on appeal; cert denied 2021; contemporaneous reporting documented internal asbestos testing knowledge from the 1970s. The company disputes the findings and has pursued bankruptcy-structuring of the liabilities, which courts have twice rejected.
- 2021Opioids — $5B national settlement contribution — Contributed approximately $5B to the national opioid settlement covering marketing of prescription opioids, and agreed to exit the opioid business in the US. Settled without admission of liability — marked negligent rather than intentional because no judicial finding of knowing deception was entered against J&J in the settled claims, unlike the RICO finding against the tobacco manufacturers.